Visterra Inc (NASDAQ:VIST) shares were up 15.4% on Wednesday . The company traded as high as $7.03 and last traded at $6.74, approximately 525,900 shares changed hands during trading. An increase of 151% from the average daily volume of 209,316 shares. The stock had previously closed at $5.84.
The company’s 50-day moving average price is $5.47.
Hedge funds have recently made changes to their positions in the stock. Boston Partners acquired a new position in shares of Visterra in the third quarter valued at approximately $5,067,000. Dean Capital Investments Management LLC acquired a new position in shares of Visterra in the third quarter valued at approximately $341,000. Finally, FNY Investment Advisers LLC acquired a new position in shares of Visterra in the third quarter valued at approximately $27,000.
Visterra Inc is a United States-based biotechnology company. The Company uses its Atomic Interaction Network analysis to identify disease targets and design effective therapeutics. The Company’s technology is based on its Hierotope Platform, which identifies an area, or epitope, on the target protein, glycoprotein or glycan that is fundamental to its structure and function.
Featured Story: Market Capitalization
Receive News & Ratings for Visterra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Visterra and related companies with MarketBeat.com's FREE daily email newsletter.